Simplex Trading
CBIO

Simplex Trading’s Crescent Biopharma CBIO Stock Holding History

Simplex Trading’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-907
Closed -$94.3K – 9148
2024
Q1 		$271K Buy
907
+183
+25% +$54.7K ﹤0.01% 4518
2023
Q4 		$170K Buy
+724
New +$113K ﹤0.01% 4825
2023
Q3 		– Sell
-183
Closed -$28.9K – 9063
2023
Q2 		$31K Buy
+183
New +$30.7K ﹤0.01% 6317
2023
Q1 		– Sell
-676
Closed -$152K – 9403
2022
Q4 		$204K Buy
676
+654
+2,973% +$96.4K ﹤0.01% 4203
2022
Q3 		$1K Buy
+22
New +$1.58K ﹤0.01% 9539
2022
Q2 		– Sell
-41
Closed -$3.04K – 10347
2022
Q1 		$4K Sell
41
-952
-96% -$112K ﹤0.01% 9555
2021
Q4 		$142K Buy
+993
New +$180K ﹤0.01% 5684
2021
Q2 		– Sell
-37
Closed -$9.42K – 10260
2021
Q1 		$11K Buy
37
+35
+1,750% +$12.5K ﹤0.01% 7838
2020
Q4 		$0 Sell
2
-73
-97% -$25.6K ﹤0.01% 8587
2020
Q3 		$23K Hold
75
– – ﹤0.01% 6269
2020
Q2 		$28K Buy
75
+61
+436% +$17.3K ﹤0.01% 5963
2020
Q1 		$3K Buy
+14
New +$5.35K ﹤0.01% 7056
2019
Q3 		– Sell
-23
Closed -$14.8K – 7464
2019
Q2 		$27K Sell
23
-202
-90% -$242K ﹤0.01% 5353
2019
Q1 		$280K Buy
225
+181
+411% +$207K ﹤0.01% 3257
2018
Q4 		$41K Buy
+44
New +$52.9K ﹤0.01% 4716
2018
Q3 		– Sell
-8
Closed -$13K – 7628
2018
Q2 		$13K Sell
8
-13
-62% -$22.4K ﹤0.01% 6168
2018
Q1 		$33K Sell
21
-29
-58% -$60.3K ﹤0.01% 2847
2017
Q4 		$84K Sell
50
-91
-65% -$120K ﹤0.01% 1939
2017
Q3 		$197K Buy
141
+122
+642% +$143K 0.01% 1199
2017
Q2 		$21K Buy
+19
New +$15.7K ﹤0.01% 3251

Other funds holding CBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Simplex Trading's CBIO Position: Q2 2024 in Review

Simplex Trading sold out of Crescent Biopharma (CBIO) in Q2 2024, closing a stake of 907 shares — an estimated $94.3K sold.

Simplex Trading first reported a position in CBIO in Q2 2017 and held it in 20 quarters. The position peaked at $280K in Q1 2019. 35 funds tracked by Wall St. Rank hold CBIO as of Q2 2024.

  • Simplex Trading reported no remaining Crescent Biopharma position as of Q2 2024 after selling out during the quarter.
  • Simplex Trading sold 907 Crescent Biopharma shares in Q2 2024, an estimated $94.3K.
  • Simplex Trading first reported a position in Crescent Biopharma in Q2 2017 and held it in 20 quarters.
  • Simplex Trading's Crescent Biopharma position peaked at $280K in Q1 2019.
  • 35 funds tracked by Wall St. Rank held Crescent Biopharma as of Q2 2024.

Based on Simplex Trading's 13F filing for Q2 2024, filed 25 Jul 2024.